HRAS, EGFR, MET, and RON are recurrently activated by provirus insertion in MAV-2 retrovirus-induced liver tumors.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28768863)

Published in J Virol on August 02, 2017

Authors

Vladimir Pecenka1, Petr Pajer2, Vít Karafiat2, Petra Kasparova3, Jana Dudlova4, Michal Dvorak2

Author Affiliations

1: Institute of Molecular Genetics, Academy of Sciences CR, Prague, Czech Republic pecenkav@img.cas.cz.
2: Institute of Molecular Genetics, Academy of Sciences CR, Prague, Czech Republic.
3: Fingerland's Department of Pathology, School of Medicine, Charles University, Hradec Králové, Czech Republic.
4: Chambon s.r.o., Prague, Czech Republic.

Articles cited by this

Hepatocellular carcinoma. Lancet (2003) 22.54

Activation of a cellular onc gene by promoter insertion in ALV-induced lymphoid leukosis. Nature (1981) 17.31

Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences. PLoS Biol (2004) 8.27

Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia. Hepatology (2009) 5.68

New genes involved in cancer identified by retroviral tagging. Nat Genet (2002) 4.14

Terminology of nodular hepatocellular lesions. Hepatology (1995) 3.87

Activation of the cellular oncogene c-erbB by LTR insertion: molecular basis for induction of erythroblastosis by avian leukosis virus. Cell (1983) 3.45

Retroviral insertional mutagenesis: past, present and future. Oncogene (2005) 2.63

Distinct pathways of genomic progression to benign and malignant tumors of the liver. Proc Natl Acad Sci U S A (2007) 2.56

Multiple proto-oncogene activations in avian leukosis virus-induced lymphomas: evidence for stage-specific events. Mol Cell Biol (1989) 2.53

Retroviral insertional mutagenesis as a strategy to identify cancer genes. Biochim Biophys Acta (1996) 2.13

High-throughput insertional mutagenesis screens in mice to identify oncogenic networks. Nat Rev Cancer (2009) 2.06

ras gene Amplification and malignant transformation. Mol Cell Biol (1985) 2.02

Distribution of targets for avian retrovirus DNA integration in vivo. Genes Dev (1994) 1.80

The oncogenic effects of nontransforming viruses from avian myeloblastosis virus. Cancer Res (1969) 1.70

c-erbB activation in avian leukosis virus-induced erythroblastosis: clustered integration sites and the arrangement of provirus in the c-erbB alleles. Proc Natl Acad Sci U S A (1985) 1.62

Integration targeting by avian sarcoma-leukosis virus and human immunodeficiency virus in the chicken genome. J Virol (2005) 1.61

Ras stabilization through aberrant activation of Wnt/β-catenin signaling promotes intestinal tumorigenesis. Sci Signal (2012) 1.56

The epidermal growth factor receptor variant III (EGFRvIII): where wild things are altered. FEBS J (2013) 1.47

Pathological classification of intrahepatic cholangiocarcinoma based on a new concept. World J Hepatol (2010) 1.41

The protooncogene c-sea encodes a transmembrane protein-tyrosine kinase related to the Met/hepatocyte growth factor/scatter factor receptor. Proc Natl Acad Sci U S A (1993) 1.36

Diverse mechanisms of AKT pathway activation in human malignancy. Curr Cancer Drug Targets (2013) 1.33

Truncated RON tyrosine kinase drives tumor cell progression and abrogates cell-cell adhesion through E-cadherin transcriptional repression. Cancer Res (2004) 1.26

Biologically active proviral clone of myeloblastosis-associated virus type 1: implications for the genesis of avian myeloblastosis virus. J Virol (1985) 1.23

Activation of c-erbB in avian leukosis virus-induced erythroblastosis leads to the expression of a truncated EGF receptor kinase. EMBO J (1985) 1.13

Telomerase reverse transcriptase expression elevated by avian leukosis virus integration in B cell lymphomas. Proc Natl Acad Sci U S A (2007) 1.08

The Met receptor tyrosine kinase: a key player in oncogenesis and drug resistance. Pharmacol Ther (2013) 1.07

Hypermethylation of Ron proximal promoter associates with lack of full-length Ron and transcription of oncogenic short-Ron from an internal promoter. Oncogene (2007) 1.02

Short-Form Ron Promotes Spontaneous Breast Cancer Metastasis through Interaction with Phosphoinositide 3-Kinase. Genes Cancer (2011) 1.01

Mouse models in liver cancer research: a review of current literature. World J Gastroenterol (2008) 0.98

The MYC, TERT, and ZIC1 genes are common targets of viral integration and transcriptional deregulation in avian leukosis virus subgroup J-induced myeloid leukosis. J Virol (2013) 0.93

Identification of potential human oncogenes by mapping the common viral integration sites in avian nephroblastoma. Cancer Res (2006) 0.92

The MET gene is a common integration target in avian leukosis virus subgroup J-induced chicken hemangiomas. J Virol (2015) 0.89

Pathogenic potential of myeloblastosis-associated virus: implication of env proteins for osteopetrosis induction. Virology (1993) 0.88

The twist gene is a common target of retroviral integration and transcriptional deregulation in experimental nephroblastoma. Oncogene (2003) 0.88

The DEN and CCl4 -Induced Mouse Model of Fibrosis and Inflammation-Associated Hepatocellular Carcinoma. Curr Protoc Pharmacol (2014) 0.86

Genome-wide analysis of alpharetroviral integration in human hematopoietic stem/progenitor cells. Genes (Basel) (2014) 0.78

Comparative aspects of the chicken immunogenetics (review). Folia Biol (Praha) (1997) 0.77

From chronic liver disorders to hepatocellular carcinoma: Molecular and genetic pathways. World J Gastrointest Oncol (2010) 0.77

The noncoding and surface envelope coding sequences of myeloblastosis-associated virus are respectively responsible for nephroblastoma development and renal hyperplasia. J Virol (1996) 0.77

Avian nephroblastomas induced by a retrovirus (MAV-2) lacking oncogene. II. Search for common sites of proviral integration in tumour DNA. Folia Biol (Praha) (1988) 0.77

Industasis, a promotion of tumor formation by nontumorigenic stray cells. Cancer Res (2009) 0.76

Short-form Ron is a novel determinant of ovarian cancer initiation and progression. Genes Cancer (2016) 0.75